Abstract
BackgroundApproximately one-third of diffuse large B cell lymphoma (DLBCL) patients exhibit co-expression of MYC and BCL2 (double-expressor lymphoma, DEL) and have a dismal prognosis. Targeted inhibition of the anti-apoptotic protein...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have